BO-112 - Highlight Therapeutics

1 2 3 4 5

BO-112 acts similarly to a virus helping the immune system detect cancerous cells.

BO-112 is a polyinosinic-polycytidylic acid (Poly I:C)-based non-coding double-stranded RNA (dsRNA) formulated with polyethyleneimine (PEI)

Some tumor cells mask their presence to the body’s immune system.

Without treatment tumor cells are not detected by the immune system and grow without interference.

BO-112 when injected, mimics a viral infection, therefore activating the innate immune system.

BO-112 helps your adaptive (tumor-specific) immune system to recognize and fight cancer cells

BO-112 causes direct tumor cell disruption further helping the immune system to recognize the tumor